{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:05:25Z","timestamp":1772136325795,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The deleterious impact of Coronavirus SARS CoV-2 related Disease (COVID-19) in patients with chronic liver disease (CLD) has been previously described. We report here data from the largest French \u201creal-life\u201d cohort. Patients with CLD regardless of etiology and liver transplant recipients who developed COVID-19 confirmed by a positive PCR and\/or an evocative chest CT scan were included. The primary outcome was 30-days mortality. Prognostic factors were analyzed using both uni- and multivariate models in subgroups of transplanted and non-transplanted patients. Between August, 2020, and December, 2021, 1219 patients were included, mostly men (n\u2009=\u2009754), median age 61 years, 477 patients with advanced CLD (decompensated (Child\u2013Pugh B or C) in 164 patients); 366 patients were immunocompromised, including 271 organ transplant recipients. Hospitalization in intensive care unit was required in 11% of cases. The median follow-up was 68 days. The overall 30-days mortality was 13% (159 deaths, 62% related to extra-hepatic causes). Among transplant recipients, age was the only independent prognostic factor. In the non-transplanted population, the independent prognostic factors were advanced liver fibrosis (F3 or F4, HR 2.5), obesity (HR 1.56) and age (HR 1.03), whereas immunosuppression was not. Within the subgroup of patients with advanced CLD, decompensation (Child\u2013Pugh B or C) was an independent predictor of mortality (HR 3.8). In conclusion, our results highlight the increased vulnerability of patients with advanced CLD to COVID-19, particularly those with decompensated disease. Conversely, they confirm the absence of excess mortality related to immunosuppression, particularly in organ transplant recipients.\n                    <jats:bold>Clinical trial registration:<\/jats:bold>\n                    Clinical trial (NCT 04,375,670).\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-14213-7","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:41:15Z","timestamp":1759844475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 and chronic liver disease: results from the 1219 patients French registry"],"prefix":"10.1038","volume":"15","author":[{"given":"L.","family":"Blaise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Leboss\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Si","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heurgu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meszaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Radenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vanlemmens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Landrieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bouzbib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Barraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bardou-Jacquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Chazouill\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Latournerie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Anty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gelu-Simeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Khaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Amaddeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bernard-Chabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Moga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Roulot-Marullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Elkrief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Plessier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.-P.","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"R\u00e9my","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sultanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"de Ledinghen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Reboux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Texier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-B.","family":"Hiriart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Montialoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"de Montigny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rudler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Williet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mboup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bourli\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ganne-Carri\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"14213_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5(3), 245\u2013266 https:\/\/doi.org\/10.1016\/S2468-1253(19)30349-8(2020).","DOI":"10.1016\/S2468-1253(19)30349-8"},{"key":"14213_CR2","doi-asserted-by":"crossref","unstructured":"Baldelli, L. et al. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes. Gut Liver 17(1), 12-23 (2023).","DOI":"10.5009\/gnl220327"},{"issue":"3","key":"14213_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","volume":"74","author":"T Marjot","year":"2021","unstructured":"Marjot, T. et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J. Hepatol. 74(3), 567\u2013577 (2021).","journal-title":"J. Hepatol."},{"issue":"5","key":"14213_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","volume":"14","author":"SK Sarin","year":"2020","unstructured":"Sarin, S. K. et al. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol. Int. 14(5), 690\u2013700 (2020).","journal-title":"Hepatol. Int."},{"issue":"5","key":"14213_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","volume":"18","author":"T Marjot","year":"2021","unstructured":"Marjot, T. et al. COVID_19 and liver disease: mechanistic and clinical perspectives. Nat. Rev. Gastroenterol. Hepatol. 18(5), 348\u2013364 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"14213_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jhep.2021.04.052","volume":"75","author":"V Mallet","year":"2021","unstructured":"Mallet, V., Beeker, N., Bouam, S., Sogni, P. & Pol, S. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020. J. Hepatol. 75(4), 848\u2013855 (2021).","journal-title":"J. Hepatol."},{"issue":"1","key":"14213_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jhep.2022.07.028","volume":"78","author":"X Gao","year":"2023","unstructured":"Gao, X. et al. Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States. J. Hepatol. 78(1), 16\u201327 (2023).","journal-title":"J. Hepatol."},{"issue":"4","key":"14213_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/hep.31487","volume":"72","author":"MA Hundt","year":"2020","unstructured":"Hundt, M. A., Deng, Y., Ciarleglio, M. M., Nathanson, M. H. & Lim, J. K. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1827 Patients in a Major U.S. Hospital Network. Hepatology 72(4), 1169\u20131176 (2020).","journal-title":"Hepatology"},{"issue":"7","key":"14213_CR9","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/MEG.0000000000001817","volume":"33","author":"K Wijarnpreecha","year":"2021","unstructured":"Wijarnpreecha, K. et al. COVID-19 and liver injury: a meta-analysis. Eur. J. Gastroenterol. Hepatol. 33(7), 990\u2013995 (2021).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"38","key":"14213_CR10","doi-asserted-by":"publisher","first-page":"101025","DOI":"10.1016\/j.eclinm.2021.101025","volume":"13","author":"AV Kulkarni","year":"2021","unstructured":"Kulkarni, A. V. et al. Impact of COVID-19 on liver transplant recipients\u2013A systematic review and meta-analysis. EClinicalMedicine. 13(38), 101025 (2021).","journal-title":"EClinicalMedicine."},{"issue":"12","key":"14213_CR11","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1038\/s41598-022-08947-x","volume":"22","author":"M Guarino","year":"2022","unstructured":"Guarino, M. et al. COVID_19 in liver transplant recipients: incidence, hospitalization and outcomes in an Italian prospective double-centre sudy. Sci. Rep. 22(12), 4831 (2022).","journal-title":"Sci. Rep."},{"issue":"9","key":"14213_CR12","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.cgh.2022.03.017","volume":"20","author":"S Deutsch-Link","year":"2022","unstructured":"Deutsch-Link, S. et al. Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic. Clin. Gastroenterol. Hepatol. 20(9), 2142-2144.e2 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"22","key":"14213_CR13","first-page":"03145","volume":"S0168\u20138278","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Wang, Y., Duan, G. & Yang, H. NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis. J. Hepatol. S0168\u20138278(22), 03145\u201303152 (2022).","journal-title":"J. Hepatol."},{"issue":"4","key":"14213_CR14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T. & Ripoll, C. Baveno VII Faculty: Baveno VII - Renewing consensus in portal hypertension. J. Hepatol. 76(4), 959\u2013974 (2022).","journal-title":"J. Hepatol."},{"issue":"4","key":"14213_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ueg2.12232","volume":"10","author":"JF Brozat","year":"2022","unstructured":"Brozat, J. F. et al. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United Eur. Gastroenterol. J. 10(4), 409\u2013424 (2022).","journal-title":"United Eur. Gastroenterol. J."},{"issue":"5","key":"14213_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1053\/j.gastro.2021.07.010","volume":"161","author":"J Ge","year":"2021","unstructured":"Ge, J., Pletcher, M. J. & Lai, J. C. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study. Gastroenterology 161(5), 1487-1501.e5 (2021).","journal-title":"Gastroenterology"},{"issue":"1","key":"14213_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12876-021-02017-8","volume":"21","author":"TG Simon","year":"2021","unstructured":"Simon, T. G. et al. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study. BMC Gastroenterol. 21(1), 439 (2021).","journal-title":"BMC Gastroenterol."},{"issue":"7821","key":"14213_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 584(7821), 430\u2013436 (2020).","journal-title":"Nature"},{"issue":"1","key":"14213_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000510758","volume":"39","author":"OE Anastasiou","year":"2021","unstructured":"Anastasiou, O. E., Korth, J., Herbstreit, F., Witzke, O. & Lange, C. M. Mild versus Severe Liver Injury in SARS-CoV-2 Infection. Dig. Dis. 39(1), 52\u201357 (2021).","journal-title":"Dig. Dis."},{"issue":"11","key":"14213_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S2468-1253(20)30271-5","volume":"5","author":"GJ Webb","year":"2020","unstructured":"Webb, G. J. et al. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol. Hepatol. 5(11), 1008\u20131016 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"6","key":"14213_CR21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jhep.2021.01.021","volume":"74","author":"T Marjot","year":"2021","unstructured":"Marjot, T. et al. SARS-CoV-2 infection in patients with autoimmune hepatitis. J. Hepatol. 74(6), 1335\u20131343 (2021).","journal-title":"J. Hepatol."},{"issue":"9","key":"14213_CR22","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1111\/liv.14575","volume":"40","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Metabolic-associated fatty liver disease is associated with severity of COVID-19. Liver Int. 40(9), 2160\u20132163 (2020).","journal-title":"Liver Int."},{"issue":"2","key":"14213_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.dld.2020.09.007","volume":"53","author":"L Pan","year":"2021","unstructured":"Pan, L. et al. Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis. Dig. Liver Dis. 53(2), 153\u2013157 (2021).","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"14213_CR24","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.jhepr.2021.100260","volume":"3","author":"S Mu\u00f1oz-Mart\u00ednez","year":"2021","unstructured":"Mu\u00f1oz-Mart\u00ednez, S. et al. Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Rep. 3(3), 100260 (2021).","journal-title":"JHEP Rep."},{"issue":"1","key":"14213_CR25","doi-asserted-by":"publisher","first-page":"100199","DOI":"10.1016\/j.jhepr.2020.100199","volume":"3","author":"G Amaddeo","year":"2021","unstructured":"Amaddeo, G. et al. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area. JHEP Rep. 3(1), 100199 (2021).","journal-title":"JHEP Rep."},{"issue":"1","key":"14213_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.dld.2021.09.017","volume":"54","author":"T Aparicio","year":"2022","unstructured":"Aparicio, T. et al. Effect of lockdown on digestive system cancer care amongst older patients during the first wave of COVID-19: The CADIGCOVAGE multicentre cohort study. Dig. Liver Dis. 54(1), 10\u201318 (2022).","journal-title":"Dig. Liver Dis."},{"key":"14213_CR27","first-page":"565","volume":"9","author":"P Hunyady","year":"2022","unstructured":"Hunyady, P. et al. Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study. Clin. Infect. Dis. 9, 565 (2022).","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"14213_CR28","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.32582","volume":"76","author":"L Hartl","year":"2022","unstructured":"Hartl, L. et al. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hepatology 76(6), 1563\u20131575 (2022).","journal-title":"Hepatology"},{"issue":"5","key":"14213_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jhep.2021.02.007","volume":"74","author":"Keta-Cov research group","year":"2021","unstructured":"Keta-Cov research group. Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. J. Hepatol. 74(5), 1243\u20131244 (2021).","journal-title":"J. Hepatol."},{"issue":"4","key":"14213_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jhep.2022.07.008","volume":"77","author":"T Marjot","year":"2022","unstructured":"Marjot, T. et al. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper. J. Hepatol. 77(4), 1161\u20131197 (2022).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14213-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:03:45Z","timestamp":1760234625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14213-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14213"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14213-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4800973\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34869"}}